5-氟-6-羟基萘-1-羧酸 | 847802-85-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 5-氟-6-羟基萘-1-羧酸
• 英文名称: 5-fluoro-6-hydroxy-1-naphthoic acid
• 英文别名: 5-Fluoro-6-hydroxynaphthalene-1-carboxylic acid
• CAS: 847802-85-1
• 化学式: C₁₁H₇FO₃
• 分子量: 206.173
• InChiKey: BXYLFSCZRGHQSK-UHFFFAOYSA-N

物化性质

• 沸点：
  427.4±25.0 °C(Predicted)
• 密度：
  1.486±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2918290000

反应信息

• 作为反应物：
  描述：

  5-氟-6-羟基萘-1-羧酸 、 4-氯 -6,7-二甲氧基喹啉 在 caesium carbonate 作用下， 以 二甲基亚砜 为溶剂， 以56%的产率得到6-(6,7-dimethoxyquinolin-4-yloxy)-5-fluoro-1-naphthoic acid
  参考文献：
  名称：

  Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation

  摘要：

  A series of naphthyl-based compounds were synthesized as potential inhibitors of vascular endothelial growth factor (VEGF) receptors. Investigations of structure-activity relationships led to the identification of a series of naphthamides that are potent inhibitors of the VEGF receptor tyrosine kinase family. Numerous analogues demonstrated low nanomolar inhibition of VEGF-dependent human umbilical vein endothelial cell (HUVEC) proliferation, and of these several compounds possessed favorable pharmacokinetic (PK) profiles. In particular, compound 48 demonstrated significant antitumor efficacy against established HT29 human colon adenocarcinoma xenografts implanted in athymic mice. A full account of the preparation, structure-activity relationships, pharmacokinetic properties, and pharmacology of analogues within this series is presented.

  DOI：

  10.1021/jm701097z
• 作为产物：
  描述：

  6-羟基-1-萘甲酸 在 氯化亚砜 、 水 、 Selectfluor 、 lithium hydroxide 作用下， 以 四氢呋喃 、 乙腈 为溶剂， 反应 38.0h， 生成 5-氟-6-羟基萘-1-羧酸
  参考文献：
  名称：

  苯胺嘧啶类化合物、其制备方法和医药用途

  摘要：

  本发明涉及如式（Ⅰ）所示结构的苯胺嘧啶类化合物、其药用盐、其前药及其水合物或溶剂合物，也涉及所述化合物的制备方法、包含所述化合物的药物组合物以及其作为蛋白酪氨酸激酶抑制剂，特别是作为VEGFR‑2抑制剂，在制备预防和/或治疗与异常血管新生相关疾病的药物中的用途。

  公开号：

  CN104829542B

文献信息

• [EN] NAPHTHALENE CARBOXAMIDES AND THEIR DERIVATIVES USEFUL AS NEW ANTI-ANGIOGENIC AGENTS<br/>[FR] CARBOXAMIDES DE NAPHTALENE ET LEURS DERIVES UTILES COMME NOUVEAUX AGENTS ANTI-ANGIOGENIQUES
  申请人：PFIZER

  公开号：WO2005021553A1

  公开（公告）日：2005-03-10

  The invention relates to compounds represented by Formula (I) and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein each of R1a-d , R2a-b , R3, and X1 are defined herein, The invention also relates to pharmaceutical compositions containing the compounds of Formula (I) and to methods of treating hyperproliferative disorders in a mammal by administering compounds of Formula(l).

  该发明涉及由化学式（I）表示的化合物，以及这些化合物或其前药、药学上可接受的盐或溶剂，其中R1a-d、R2a-b、R3和X1中的每一个在此处被定义。该发明还涉及含有化合物的药物组合物的制备方法，并通过给予化合物治疗哺乳动物的高增殖性疾病的方法。
• Napthalene carboxamides and their derivatives useful as new anti-angiogenic agents
  申请人：Lou Jihong

  公开号：US20050070508A1

  公开（公告）日：2005-03-31

  The invention relates to compounds represented by Formula (I): and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein each of R 1a-d , R 2a-b , R 3 , and X 1 are defined herein. The invention also relates to pharmaceutical compositions containing the compounds of Formula (I) and to methods of treating hyperproliferative disorders in a mammal by administering compounds of Formula (I).

  本发明涉及由公式（I）表示的化合物，以及它们的前药、所述化合物或前药的药学上可接受的盐或溶剂，其中R1a-d、R2a-b、R3和X1在此被定义。本发明还涉及含有公式（I）化合物的制药组合物，并通过给哺乳动物施用公式（I）化合物的方法治疗增生性疾病。
• Compounds and methods of use
  申请人：Potashman Michele

  公开号：US20060241115A1

  公开（公告）日：2006-10-26

  Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选化合物对于预防和治疗HGF介导的疾病等具有有效性。本发明涵盖了新颖的化合物、类似物、前药和其药学上可接受的盐，以及用于预防和治疗涉及癌症等疾病和其他疾病或状况的药物组合物和方法。该发明还涉及制备此类化合物的过程，以及在此类过程中有用的中间体。
• NAPHTHALENE CARBOXAMIDES AND THEIR DERIVATIVES USEFUL AS NEW ANTI-ANGIOGENIC AGENTS
  申请人：PFIZER INC.

  公开号：EP1660503A1

  公开（公告）日：2006-05-31
• COMPOUNDS AND METHODS OF USE
  申请人：AMGEN INC.

  公开号：EP1713484A2

  公开（公告）日：2006-10-25